Glycosidation of narbonolide with mycaminose was attempted by feeding narbonolide during the fermentation of a parent or a mutant strain of Streptomyces platensis, a producer of 16-membered macrolide antibiotics, platenomycins.
Hitherto, a number of aglycones of macrolide antibiotics have been isolated,'-') and used for the elucidation of the biosynthetic pathway of this antibiotic group, e.g. erythromycin,') picromycin') and platenomycins.11)
As reported previously, the authors isolated narbonolide, the aglycone of narbomycin, from the culture of Streptomyces venezuelae MCRL-0376 which produced narbomycin and picromycin as major antibiotics,'',' ') and succeeded in the bioconversion of biologically inactive narbonolide into active antibiotics (narbomycin and picromycin) by glycosidation of the aglycone.9)
In 1972, rosamicin was reported") to consist of an aglycone identical with that of cirramycin AI and a sugar which was identified as desosamine. Considering that rosamicin is constructed from a 16-membered aglycone and a sugar usually found in 12-or 14-membered macrolide antibiotics, it was conversely assumed that a new antibiotic might be obtained by combining a sugar normally present in 16-membered macrolide antibiotics with a 14-membered macrolide aglycone.
Thus, glycosidation of narbonolide with mycaminose (a sugar component of 16-membered macrolide antibiotics, such as platenomycin, leucomycin, spiramycin, cirramycin, tylosin, carbomycin etc.)
was attempted by adding narbonolide during the fermentation of platenomycin-producing Streptomyces platensis MCRL-0388141 and its blocked mutant (strain U-21). Two new compounds I and II were successfully derived from narbonolide.
In this paper, the isolation and characterization of these biotransformed compounds I and II as 5-0-mycaminosyl narbonolide and 9-dihydro-5-O-mycaminosyl narbonolide respectively is described.
Microorganism and Fermentation
The strains employed in this investigation were Streptomyces platensis subsp. malvinus MCRL-0388, a producer of the platenomycins and a mutant strain U-21. Strain U-21 was derived by treatment of the parent strain with ultraviolet irradiation. Strain U-21 was completly blocked in an early stage of platenomycin biosynthesis and unable to synthesize the antibiotics de novo. However, this * Present Address; Faculty of Pharmacy , Meijo University, Tempaku-ku, Nagoya, Japan.
mutant can synthesize platenomycins in the presence of certain intermediates such as platenolides I and II.10)
The fermentations of these organisms were carried out as follows: seed cultures were obtained by incubating the spores at 27'C for 62 hours on a rotary shaker (180 rpm) in 100 ml of medium consisting of glucose 20 g, meat extract 7.5 g, yeast extract 3 g and NaCI 3 g per liter (tap water, pH unadjusted) prepared in 500 ml Erlenmeyer flasks. Then, the seed culture was inoculated at a level of 2;0 (v/v) into 500 ml Erlenmeyer flasks containing 100 ml of fermentation medium consisting of corn starch 15 g, soy bean meal 15 g, cornsteep liquor 1 g, yeast extract 2 g, NaCI 5 g and CaCO3 2 g per liter (tap water, pH unadjusted), and incubated at 27°C on a rotary shaker (180 rpm). Narbonolide dissolved in ethyl alcohol was added to a 20-hour culture of the organisms at the concentrations indicated. The fermentation was further continued and analyzed for products at 20, 40, 70 and 90 hours after addition. Antibiotic activity in the broth was assayed at the times indicated by a cup plate method using Bacillus subtilis PCI-219 as a test organism.
Production of the Biotransformed Compounds I and II
The production of platenomycins by MCRL-0388 after addition of narbonolide was first examined.
Fig . I shows the result. When narbonolide was added, platenomycin production was depressed, the depression being more marked as the narbonolide concentration became higher. At the levels of 200 mcg/ml of narbonolide, only 20 mcg/ml of platenomycins was produced. The production of platenomycins was depressed to about 5 % of the control value.
Since it was expected that the organism may accumulate some narbonolide, the fermentation broth was examined by thin-layer (TL) chromatography on silicagel G (Merck) with a solvent system of chloroform -methanol -acetic acid -water (79: 11: 8: 2). The TL chromatogram of an ethyl acetate extract of the beer at 40, 70 and 90 hours after addition of narbonolide indicated the presence of two new products, tentatively designated as I and II, which increased as the added narbonolide disappeared. These compounds could be distinguished from platenomycins by their color on TL-plates (colorlation after spraying with H2S04 followed by heating: platenomycins, reddish violet or blue; I and II, light The isolation of the two new products was attempted using the fermentation beers of MCRL-0388 at an earlier stage, but many difficulties arose in the purification process because of the similar solubility of the new compounds and the platenomycins. Therefore, experiments were conducted using a mutant strain, U-21 which is unable to synthesize platenomycins. Fig. 2 shows the result of the fermentation added with platenolide I or narbonolide. Antibiotic activity was observed only when platenolide I was added to the medium, and the active products were identified as platenomycins by TLchromatography.
In contrast, the fermentation added with narbonolide gave two new compounds.
They were identical with the products noticed during the fermentation of the parent strain. Tables 1 and 2. IR spectrum of I suggested the presence of hydroxyl (3450 cm''), lactone (1740 cm-1), conjugated ketone (1695 cm-'), simple ketone (1705 cm-') functions together with ethylene linkage (1630 cm-').
UV absorption at 225 nm (log. a 4.08) in EtOH showed the presence of an a, ,8 unsaturated ketone, and the maximum at 288 nm in alkaline EtOH suggested the presence of a /3-keto-lactone system") in 1.
The 'H-NMR spectrum of I measured in CDC13 indicated the presence of seven C-methyl (8 0 .8- These data indicate that compound I is closely related to narbomycin. However, judging from its lower Rf value in TL chromatography, I was thought to be more polar in nature than narbomycin.
IR, UV and 1H-NMR spectra of I and narbomycin were hardly distinguishable. However, the mass spectra of I and narbomycin showed the 16 mass unit difference in the molecular ion (m/e 525 and 509 respectively). The intense fragment peaks of compound I at m/e 351 and 335 were identical with those of narbomycin and ascribed to an aglycone part. The intense peaks at m/e 190 and 174 were comparable respectively to m/e 174 and 158 of narbomycin. The latter two were due to a sugar moiety of narbomycin. The peaks at m/e 190 and 174 shifted to m/e 274 and 258 with a peracetyl derivative, the shifts corresponding to two acetyl units. By this comparative mass spectral analysis, the presence of mycaminose which has one more hydroxyl function than desosamine was assumed in 1, and I was presumed to be 5-0-mycaminosyl narbonolide, in which the desosamine moiety in narbomycin is replaced by mycaminose.
Hydrolysis of compound I with 6 N hydrochloric acid gave an amino sugar, which was detected to be D-mycaminose by direct comparison with an authentic sample obtained from platenomycins.
The structure of compound 11 was readily suggested, when IR, UV and 1H-NMR spectra of II Solvent system: CHCI3 -MeOH -AcOH -H20 (79: 11: 8 : 2). Consequently, II was assumed to possess a mycaminose moiety as with I. Fragment ion peaks of 11 at mle 353 and 337 may be comparable to the peaks of I at to/e 351 and 335 respectively. These peaks were ascribed to an aglycone part. However, contrary to the peaks of I which were observed unchanged in its diacetate, the peaks of II shifted to mle 395 and 379 respectively on its triacetate, the shift corresponding to one acetyl unit. Therefore, an aglycone of II may have one more hydroxyl group than I.
Considering this assumption together with the fact that H has two more hydrogens than I and lacks the a,/1-conjugated ketone system, the aglycone of II was supposed to be a dihydroaglycone of I.
Thus, II was assumed to be a dihydro-I, namely, 9-dihydro-5-O-mycaminosyl narbonolide.
The above assumption was chemically confirmed by mild oxidation of II to I. Oxidation of II with active Mn02 in CHC13 gave a dehydro derivative, whose IR, UV, Mass and 1H-NMR spectra were completely identical with I.
Biological Activity of Compounds I and II
The antimicrobial activity of compounds I and 11 were determined by an agar dilution method.
The results are shown in Table 3 . Compound I showed antibacterial activity against Gram-positive bacteria, but the activity was considerably less than that of narbomycin. On the other hand, compound II showed almost no antimicrobial activity. hitherto recognized only as a sugar present in 16-membered macrolide antibiotics. Further, it should be possible to prepare a rosamicin-like antibiotic in which mycaminose was replaced by desosamine, an amino sugar normally found to bound to 12 and/or 14-membered aglycones. This possibility will be dealt with in part 11 of this series.
As investigated by many scientists, macrolide aglycones were of great use in elucidating the biosynthetic pathway of this antibiotic group by using the aglycones as substrates or precursors in fermentation studies. By this technique, the biosynthetic pathway of narbomycin,9> picromycin" and platenomycins10I were clearly elucidated in this laboratory.
The present experiment extended the use of macrolide aglycones as a starting material for the preparation of new macrolide antibiotics. However, some problems were left unsolved. For example, no biosynthesis of a macrolide with a disaccharide moiety was observed.
In the present experiments, a compound posessing the disaccharide mycarosyl mycaminose was searched for, but the desired compound was not found.
